Similar articles

• Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.

  Kolodny EH, Brady RO, Volk BW. Kolodny EH, et al. Biochem Biophys Res Commun. 1969 Oct 22;37(3):526-31. doi: 10.1016/0006-291x(69)90947-4. Biochem Biophys Res Commun. 1969. PMID: 5388728 No abstract available.
• Further studies on the elucidation of the enzymatic defect in Tay-Sachs disease.

  Kolodny EH, Brady RO. Kolodny EH, et al. Neurology. 1970 Apr;20(4):388. Neurology. 1970. PMID: 5535010 No abstract available.
• Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs.

  Sandhoff K, Andreae U, Jatzkewitz H. Sandhoff K, et al. Pathol Eur. 1968;3(2):278-85. Pathol Eur. 1968. PMID: 5688464 No abstract available.
• The enzymology of Tay-Sachs disease and its variant forms.

  Tallman JF. Tallman JF. UCLA Forum Med Sci. 1975;(18):479-99. doi: 10.1016/b978-0-12-139050-1.50035-5. UCLA Forum Med Sci. 1975. PMID: 812231 Review. No abstract available.
• Disorders of ganglioside metabolism.

  Brady RO, Kolodny EH. Brady RO, et al. Prog Med Genet. 1972;8:225-41. Prog Med Genet. 1972. PMID: 4336471 Review. No abstract available.